This observation implied that a higher level of GALNT14 in pancreatic cancer cells was associated with a poorer clinical outcome, similar to the findings reported in HCC, albeit the correlation between the GALNT14 expression levels and genotypes was opposite in HCC and pancreatic cancer. The gene discussed is GALNT14; the disease is pancreatic neoplasm.